Kingstone Stockholders Approve Company Proposals at Annual Meeting
Get Alerts KINS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.3%
EPS Growth %: +25.7%
Join SI Premium – FREE
KINGSTON, NY / ACCESSWIRE / August 7, 2024 / Kingstone Companies, Inc. (Nasdaq: KINS) (the "Company" or "Kingstone"), a Northeast regional property and casualty insurance holding company, announced the results of its annual meeting of stockholders, held today at the Company's headquarters in Kingston, New York. At the meeting:
The Company's eight directors, Barry B. Goldstein, Meryl S. Golden, Floyd R. Tupper, Timothy P. McFadden, William L. Yankus, Carla A. D'Andre, Manmohan Singh and Thomas Newgarden were elected to a one-year term, to expire at the next annual meeting of stockholders.
The Company's 2024 Equity Participation Plan was approved.
The appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified.
The compensation of the Company's named executive officers, as set forth in the proxy statement for the meeting, was approved.
About Kingstone Companies, Inc.
Kingstone is a northeast regional property and casualty insurance holding company whose principal operating subsidiary is Kingstone Insurance Company ("KICO"). KICO is a New York domiciled carrier writing business through retail and wholesale agents and brokers. KICO is actively writing personal lines and commercial auto insurance in New York, and in 2023 was the 15th largest writer of homeowners insurance in New York. KICO is also licensed in New Jersey, Rhode Island, Massachusetts, Connecticut, Pennsylvania, New Hampshire, and Maine.
Investor Relations Contact:
Karin Daly
Vice President
The Equity Group Inc.
[email protected]
SOURCE: Kingstone Companies, Inc
View the original press release on accesswire.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- EagleOne Metals closes $225,199 non-brokered private placement
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
Create E-mail Alert Related Categories
ACCESS Newswire, Press ReleasesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share